Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
Jpn J Clin Oncol. 2022 Dec 8:hyac184. doi: 10.1093/jjco/hyac184. Online ahead of print.NO ABSTRACTPMID:36484305 | DOI:10.1093/jjco/hyac184
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Hidetoshi Kawaguchi Yutaka Yamamoto Shigehira Saji Norikazu Masuda Takahiro Nakayama Kenjiro Aogi Keisei Anan Shoichiro Ohtani Nobuaki Sato Toshimi Takano Eriko Tokunaga Seigo Nakamura Yoshie Hasegawa Masaya Hattori Tomomi Fujisawa Satoshi Morita Miki Yam Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Medroxyprogesterone | Men | Menopause | Study